EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Prognostic Impact of Being Underweight in Patients Undergoing Mitral TEER: The OCEAN-Mitral Registry

Ryosuke Higuchi iD, Masaki Izumo, Yuki Izumi, Mike Saji, Mitsuaki Isobe, Yoshihiro Akashi, Masanori Yamamoto, Masahiko Asami, Yusuke Enta, Masaki Nakashima, Shinichi Shirai, Shingo Mizuno und 14 weitere

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15047 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Ryosuke Higuchi und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. Hauptthemen laut MEDLINE: Registries, Thinness, Mitral Valve Insufficiency, Mitral Valve. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Edwards Lifesciences, Medtronic Japan, Boston Scientific Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Mitral transcatheter edge-to-edge repair (M-TEER) is a valid treatment option for severe mitral regurgitation (MR), necessitating accurate risk stratification of M-TEER candidates for effective patient selection, optimal periprocedural care and improved long-term outcomes. The body mass index (BMI) is a simple and practical prognostic index, and the obesity paradox has been widely reported. Methods and Results Between April 2018 and June 2021, 2149 patients undergoing M-TEER were registered in the prospective multicentre registry and classified into three groups: underweight (BMI < 18.5 kg/m2), normal weight (18.5 ≤ BMI < 25 kg/m2) and overweight and obese (25 kg/m2 ≦ BMI) [Correction added on 17 October 2024, after first online publication: In the preceding sentence, “18.5 ☆ BMI < 25 kg/m2” and “25 kg/m2 ☆ BMI” have been corrected to “18.5 ≤ BMI < 25 kg/m2” and “25 kg/m2 ≦ BMI” in this version.] The impact of underweight on the all-cause, cardiovascular and non-cardiovascular mortality following M-TEER was evaluated [follow-up duration: 436 (363–733) days]. The participants (median BMI: 21.1 kg/m2) were categorized as underweight (n = 450, 20.9%), normal weight (n = 1409, 65.6%) and overweight and obese (n = 290, 13.5%). Compared with the other two groups, the underweight group exhibited several negative prognostic factors, including older age, frailty, no dyslipidaemia, hypoalbuminaemia, residual MR and non-home discharge. Underweight patients had the highest rate of all-cause, cardiovascular and non-cardiovascular mortality, whereas those in the other two groups were similar. As per the multivariate analysis, underweight itself was associated with all-cause mortality (hazard ratio: 1.52, 95% confidence interval: 1.17–1.97, P = 0.009) and cardiovascular mortality (hazard ratio: 1.45, 95% confidence interval: 1.04–2.01, P = 0.028).

Conclusions

Underweight patients had the highest mortality rate after M-TEER. Comorbidities, residual MR, discharge disposition and underweight status were correlated with postprocedural outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesThinnessMitral Valve InsufficiencyMitral ValveCardiac CatheterizationHeart Valve Prosthesis ImplantationHumansMaleFemalePrognosisProspective StudiesAgedBody Mass IndexFollow-Up StudiesMiddle AgedRisk FactorsSurvival RateRisk Assessment

Stichwörter der Autor:innen

body mass indexobesity paradoxoutcometranscatheter edge‐to‐edge repairunderweight

Autor:innen und Institutionen

  • Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.
  • Division of Cardiology, St. Marianna University School of Medicine Hospital, Kawasaki, Japan.
  • Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan.
  • Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.
  • Department of Cardiology, Toyohashi Heart Center, Toyohashi, Japan.
  • Division of Cardiology, Gifu Heart Center, Gifu, Japan.

ORCID-Profile: Ryosuke Higuchi

Förderung

  • Edwards Lifesciences
  • Medtronic Japan
  • Boston Scientific Corporation
  • Abbott Medical Japan
  • Daiichi-Sankyo

Zitieren

APA

Higuchi, R., Izumo, M., Izumi, Y., Saji, M., Isobe, M., Akashi, Y., Yamamoto, M., Asami, M., Enta, Y., Nakashima, M., Shirai, S., Mizuno, S., Watanabe, Y., Amaki, M., Kodama, K., Yamaguchi, J., Naganuma, T., Bota, H., Ohno, Y., …, & OCEAN‐Mitral Investigators (2025). Prognostic Impact of Being Underweight in Patients Undergoing Mitral TEER: The OCEAN-Mitral Registry. ESC Heart Failure. https://doi.org/10.1002/ehf2.15047

Vancouver

Higuchi R, Izumo M, Izumi Y, Saji M, Isobe M, Akashi Y, et al. Prognostic Impact of Being Underweight in Patients Undergoing Mitral TEER: The OCEAN-Mitral Registry. ESC Heart Failure. 2025. doi:10.1002/ehf2.15047

BibTeX
@article{Higuchi2025,
  author = {Higuchi, Ryosuke and Izumo, Masaki and Izumi, Yuki and Saji, Mike and Isobe, Mitsuaki and Akashi, Yoshihiro and Yamamoto, Masanori and Asami, Masahiko and Enta, Yusuke and Nakashima, Masaki and Shirai, Shinichi and Mizuno, Shingo and Watanabe, Yusuke and Amaki, Makoto and Kodama, Kazuhisa and Yamaguchi, Junichi and Naganuma, Toru and Bota, Hiroki and Ohno, Yohei and Yamawaki, Masahiro and Ueno, Hiroshi and Mizutani, Kazuki and Kubo, Shunsuke and Otsuka, Toshiaki and Hayashida, Kentaro and OCEAN‐Mitral Investigators, OCEAN‐Mitral Investigators},
  title = {Prognostic Impact of Being Underweight in Patients Undergoing Mitral TEER: The OCEAN-Mitral Registry},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15047}
}
Kostenlos starten →